DK502078A - Frefmgangsmaade til fremstilling af cephalosporansyrederivater - Google Patents

Frefmgangsmaade til fremstilling af cephalosporansyrederivater

Info

Publication number: DK502078A
Authority: DK; Denmark
Prior art keywords: procedure; acid derivatives; cephalosporanic acid; preparing; preparing cephalosporanic
Prior art date: 1977-11-14

Application number

DK502078A

Other languages

English (en)

Inventor

T Kamiya

T Teraji

Y Nakai

K Sakane

J Goto

Original Assignee

Fujisawa Pharmaceutical Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1977-11-14

Filing date

1978-11-10

Publication date

1979-05-15

1978-11-10 Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co

1979-05-15 Publication of DK502078A publication Critical patent/DK502078A/da

Links

YGBFLZPYDUKSPT-MRVPVSSYSA-N cephalosporanic acid Chemical class S1CC(COC(=O)C)=C(C(O)=O)N2C(=O)C[C@H]21 YGBFLZPYDUKSPT-MRVPVSSYSA-N 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/73—Unsubstituted amino or imino radicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
- C07D213/80—Acids; Esters in position 3
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/10—Compounds having one or more C—Si linkages containing nitrogen having a Si-N linkage

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Cephalosporin Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Pyridine Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)

DK502078A 1977-11-14 1978-11-10 Frefmgangsmaade til fremstilling af cephalosporansyrederivater DK502078A (da)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GB4735277		1977-11-14
GB1681078		1978-04-27
GB7835436		1978-09-04

Publications (1)

Publication Number	Publication Date
DK502078A true DK502078A (da)	1979-05-15

Family

ID=27257420

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK502078A DK502078A (da)	1977-11-14	1978-11-10	Frefmgangsmaade til fremstilling af cephalosporansyrederivater

Country Status (15)

Country	Link
US (3)	US4267176A (da)
JP (1)	JPS5492987A (da)
AT (1)	AT369005B (da)
AU (1)	AU523346B2 (da)
CA (1)	CA1120923A (da)
CH (1)	CH645904A5 (da)
DE (1)	DE2848912A1 (da)
DK (1)	DK502078A (da)
ES (5)	ES475035A1 (da)
FR (2)	FR2411839B1 (da)
GB (1)	GB2010840B (da)
HU (2)	HU183008B (da)
IT (1)	IT1192287B (da)
NL (1)	NL7811220A (da)
SE (2)	SE7811637L (da)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IT1192287B (it) *	1977-11-14	1988-03-31	Fujisawa Pharmaceutical Co	Derivati di acido cefalosporanico ad azione farmaceutica e relativo procedimento di preparazione
DE2818263A1 (de) *	1978-04-26	1979-11-08	Bayer Ag	Beta-lactamantibiotika
US4409214A (en) *	1979-11-19	1983-10-11	Fujisawa Pharmaceutical, Co., Ltd.	7-Acylamino-3-vinylcephalosporanic acid derivatives and processes for the preparation thereof
JPS5716886A (en) *	1980-07-04	1982-01-28	Fujisawa Pharmaceut Co Ltd	Azetidinone bearing oxo group or its salt or hydrate and their preparation
EP0156118A1 (en) *	1980-08-29	1985-10-02	Fujisawa Pharmaceutical Co., Ltd.	New starting compounds for the preparation of cephem compounds and processes for preparation thereof
US4577014A (en) *	1981-09-08	1986-03-18	Eli Lilly And Company	Thieno and furopyridinium-substituted cephalosporins
US4450270A (en) *	1981-10-02	1984-05-22	Eli Lilly And Company	Dioximino cephalosporin antibiotics
US4379787A (en) *	1981-10-02	1983-04-12	Eli Lilly And Company	Oximino-substituted cephalosporin compounds
US4402955A (en) *	1981-10-02	1983-09-06	Eli Lilly And Company	Dioximino cephalosporin antibiotics
US4501739A (en) *	1982-01-19	1985-02-26	Eli Lilly And Company	Thieno and furopyridinium-substituted cephalosporins
US4683227A (en) *	1985-07-09	1987-07-28	Eli Lilly And Company	Antibiotic derivatives of 7β-[2-(thiazol-4-yl)acetamide]-3-chloro-3-cephem-4-carboxylic acids and compositions and method of use thereof
PL1965798T3 (pl) *	2005-12-07	2012-02-29	Basilea Pharmaceutica Ag	Użyteczne antybiotyki monobaktamowe
US20130065874A1 (en)	2011-09-09	2013-03-14	Cubist Pharmaceuticals, Inc.	Methods for treating intrapulmonary infections
US8809314B1 (en)	2012-09-07	2014-08-19	Cubist Pharmacueticals, Inc.	Cephalosporin compound
US8476425B1 (en)	2012-09-27	2013-07-02	Cubist Pharmaceuticals, Inc.	Tazobactam arginine compositions
US9872906B2 (en)	2013-03-15	2018-01-23	Merck Sharp & Dohme Corp.	Ceftolozane antibiotic compositions
CA2906151A1 (en)	2013-03-15	2014-09-18	Merck Sharp & Dohme Corp.	Ceftolozane antibiotic compositions
US20140274997A1 (en)	2013-03-15	2014-09-18	Cubist Pharmaceuticals, Inc.	Cephalosporin pharmaceutical compositions
WO2015035376A2 (en)	2013-09-09	2015-03-12	Calixa Therapeutics, Inc.	Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
US8906898B1 (en)	2013-09-27	2014-12-09	Calixa Therapeutics, Inc.	Solid forms of ceftolozane

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3459746A (en) *	1965-10-04	1969-08-05	Lilly Co Eli	7 - heteromonocyclic-substituted acylamido derivatives of desacetyl cephalosporanic acid
GB1195203A (en) *	1966-06-24	1970-06-17	Glaxo Lab Ltd	Cephalosporins
CH527215A (de) *	1967-04-15	1972-08-31	Fujisawa Pharmaceutical Co	Verfahren zur Herstellung von 3,7-disubstituierten Cephalosporinderivaten
CH522677A (de) *	1969-10-10	1972-06-30	Ciba Geigy Ag	Verfahren zur Herstellung neuer Derivate der 7-Aminocephalosporansäure
FR2068419A1 (en) *	1969-10-27	1971-08-27	Fujisawa Pharmaceutical Co	Antibacterial cephalosporin compsns
IL39094A (en) *	1971-04-21	1976-05-31	Ciba Geigy Ag	7-(aminopyridiniumacetyl)-3-heterocyclylthiomethyl-cephalosporanic acid derivatives,their manufacture and pharmaceutical compositions containing them
US4017515A (en) *	1971-05-14	1977-04-12	Glaxo Laboratories Limited	α-(Etherified oximino) carboxylic acids and acid chlorides
US3966717A (en) *	1971-05-14	1976-06-29	Glaxo Laboratories Limited	7-β-Acylamido-3-carbamoyloxymethylceph-3-em-4-carboxylic acids and salts thereof
GB1399086A (en) *	1971-05-14	1975-06-25	Glaxo Lab Ltd	Cephalosporin compounds
US4033950A (en) *	1971-05-14	1977-07-05	Glaxo Laboratories Limited	3-Hydroxymethyl-7β-(2-alkoxy-or benzyloxyimino-2-arylacetamido)ceph-3-em-4-carboxylic acids and salts thereof
DE2222791A1 (de) *	1971-05-19	1972-12-07	Ciba Geigy Ag	Neue Pyridinessigsaeurederivate und Verfahren zu ihrer Herstellung
BE790287A (fr) *	1971-10-28	1973-04-19	Delalande Sa	Acides pyrimidin-6yl acethydroxamiques, leur procede de preparation et leur application en therapeutique
BE793724A (fr) *	1972-01-12	1973-07-05	Smith Kline French Lab	Procede de preparation de cephalosphorines non substituees en position 3, nouvelles cephalosporines obtenues et leur utilisation
AR208171A1 (es) *	1972-09-29	1976-12-09	Ciba Geigy Ag	Procedimiento para la obtencion de nuevos derivados del acido cef-3-em-4-carboxilico
GB1390141A (en) *	1973-01-08	1975-04-09	Ici Ltd	Pyrimidine derivatives and processes for their production
JPS5932472B2 (ja) *	1973-03-15	1984-08-09	藤沢薬品工業株式会社	２−アルキル−７−アシルアミノ−２（または３）−セフエム−４−カルボン酸類の製造法
JPS4970990A (da) *	1973-09-29	1974-07-09
US3968109A (en) *	1973-11-23	1976-07-06	E. R. Squibb & Sons, Inc.	Production of 2-(thio substituted)cephalosporin sulfoxides and 2-(thio substituted)cephalosporins
FR2262965A1 (en) *	1974-03-05	1975-10-03	Delalande Sa	Beta-(4-amino-6-methylpyrimidin-5-yl)propionic acid derivs - with antiulcer, bronchodilator, anticholinergic, hypotensive, diuretic and vasodilator activity
US4122259A (en) *	1974-08-23	1978-10-24	Glaxo Laboratories Limited	7β-[2-Aryl-2-(etherified oximino)acetamido]-3-N-substituted carbamoyloxymethylceph-3-em-4-carboxylic acids
JPS604171B2 (ja) *	1974-12-05	1985-02-01	久光製薬株式会社	新規な２−アニリノピリジン−３−酢酸誘導体の製造法
DK154939C (da) *	1974-12-19	1989-06-12	Takeda Chemical Industries Ltd	Analogifremgangsmaade til fremstilling af thiazolylacetamido-cephemforbindelser eller farmaceutisk acceptable salte eller estere deraf
CA1088049A (en) *	1975-06-03	1980-10-21	Takashi Masugi	3-substituted-7-substituted alkanamido-3-cephem-4- carboxylic acid compounds and processes for preparation thereof
US4152433A (en) *	1976-03-12	1979-05-01	Fujisawa Pharmaceutical Co., Ltd.	2-Lower alkyl-7-substituted-2 or 3-cephem-4-carboxylic acid compounds and pharmaceutical compositions
US4166115A (en) *	1976-04-12	1979-08-28	Fujisawa Pharmaceutical Co., Ltd.	Syn 7-oxoimino substituted derivatives of cephalosporanic acid
US4104469A (en) *	1977-04-15	1978-08-01	Bristol-Myers Company	7-(Syn-α-alkoxy-iminofuryl)acetamido-3-(2-methyl-2,3-dihydro-s-triazolo[4,3-b]pyridazin-3-on-6-ylthiomethyl)-3-cephem-4-carboxylic acids
GB1597848A (en) *	1976-12-27	1981-09-09	Fujisawa Pharmaceutical Co	Cephalosporin compounds and processes for the preparation thereof
IT1192287B (it) *	1977-11-14	1988-03-31	Fujisawa Pharmaceutical Co	Derivati di acido cefalosporanico ad azione farmaceutica e relativo procedimento di preparazione

1978
- 1978-11-09 IT IT29653/78A patent/IT1192287B/it active
- 1978-11-10 SE SE7811637A patent/SE7811637L/xx unknown
- 1978-11-10 AT AT0807178A patent/AT369005B/de not_active IP Right Cessation
- 1978-11-10 DK DK502078A patent/DK502078A/da not_active Application Discontinuation
- 1978-11-10 CA CA000316120A patent/CA1120923A/en not_active Expired
- 1978-11-10 DE DE19782848912 patent/DE2848912A1/de active Granted
- 1978-11-10 FR FR7831898A patent/FR2411839B1/fr not_active Expired
- 1978-11-10 GB GB7843984A patent/GB2010840B/en not_active Expired
- 1978-11-13 HU HU78FU368A patent/HU183008B/hu unknown
- 1978-11-13 NL NL7811220A patent/NL7811220A/xx not_active Application Discontinuation
- 1978-11-13 HU HU80281A patent/HU182098B/hu unknown
- 1978-11-13 CH CH1166778A patent/CH645904A5/de not_active IP Right Cessation
- 1978-11-13 AU AU41546/78A patent/AU523346B2/en not_active Expired
- 1978-11-13 ES ES475035A patent/ES475035A1/es not_active Expired
- 1978-11-14 JP JP14028678A patent/JPS5492987A/ja active Granted
1979
- 1979-03-26 FR FR7907572A patent/FR2413369A1/fr active Granted
- 1979-04-24 US US06/032,778 patent/US4267176A/en not_active Expired - Lifetime
- 1979-10-16 ES ES485066A patent/ES485066A1/es not_active Expired
- 1979-10-16 ES ES485068A patent/ES485068A1/es not_active Expired
- 1979-10-16 ES ES485065A patent/ES485065A1/es not_active Expired
- 1979-10-16 ES ES485067A patent/ES485067A1/es not_active Expired
1980
- 1980-12-05 US US06/213,684 patent/US4395411A/en not_active Expired - Lifetime
1984
- 1984-01-23 SE SE8400332A patent/SE8400332L/xx not_active Application Discontinuation
1985
- 1985-09-19 US US06/777,867 patent/US4596869A/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
FR2413369A1 (fr)	1979-07-27
SE8400332D0 (sv)	1984-01-23
JPS6320832B2 (da)	1988-04-30
IT1192287B (it)	1988-03-31
US4596869A (en)	1986-06-24
GB2010840B (en)	1982-12-22
ES485065A1 (es)	1980-06-16
ES485066A1 (es)	1980-06-16
US4395411A (en)	1983-07-26
US4267176A (en)	1981-05-12
FR2411839B1 (fr)	1985-09-27
CA1120923A (en)	1982-03-30
HU182098B (en)	1983-12-28
AT369005B (de)	1982-11-25
SE8400332L (sv)	1984-01-23
ATA807178A (de)	1982-04-15
IT7829653A0 (it)	1978-11-09
JPS5492987A (en)	1979-07-23
GB2010840A (en)	1979-07-04
DE2848912A1 (de)	1979-05-17
ES485068A1 (es)	1980-06-16
CH645904A5 (de)	1984-10-31
FR2413369B1 (da)	1984-04-06
ES475035A1 (es)	1980-01-01
AU4154678A (en)	1979-05-24
AU523346B2 (en)	1982-07-22
SE7811637L (sv)	1979-05-15
ES485067A1 (es)	1980-06-16
HU183008B (en)	1984-04-28
DE2848912C2 (da)	1990-10-04
NL7811220A (nl)	1979-05-16
FR2411839A1 (fr)	1979-07-13

Legal Events

Date	Code	Title	Description
1986-09-01	AHB	Application shelved due to non-payment

Publication	Publication Date	Title
DK151253C (da)	1988-05-16	Analogifremgangsmaade til fremstilling af 2-benzylphthalazin-4-yleddikesyrederivater
DK363179A (da)	1980-03-02	Fremgangsmaade til fremstilling af tetrazolylalkoxycarbostyrilderivater
DK457779A (da)	1980-05-01	Fremgangsmaade til fremstilling af 4-hydroxy-2-pyronderivater
DK129578A (da)	1978-09-26	Fremgangsmaade til fremstilling af oximderivater af 3-acetoxymethyl-7-aminothiazolylacetamidocephalosporansyre
DK539578A (da)	1979-07-05	Fremgangsmaade til fremstilling af pleuromutilinglycsid-derivater
DK488379A (da)	1980-05-19	Fremgangsmaade til fremstilling af polyetherderivater
DK502078A (da)	1979-05-15	Frefmgangsmaade til fremstilling af cephalosporansyrederivater
DK531178A (da)	1979-05-31	Fremgangsmaade til fremstilling af phenylglycinderivater
DK258078A (da)	1979-01-23	Fremgangsmaade til fremstilling af 7alfa-methoxy-7beta-(1,3-dithiethan-2-carboxamido) cephalosporansyre-derivater
DK196077A (da)	1978-09-16	Fremgangsmaade til fremstilling af di-n-propyleddikesyre
DK286777A (da)	1977-12-30	Fremgangsmade til fremstilling af penicillansyrederivater
DK396880A (da)	1981-03-21	Fremgangsmaade til fremstilling af cyclohexancarboxylsyrederivater
DK455877A (da)	1978-04-15	Fremgangsmaade til fremstilling af phenyleddikesyrederivater
DK129678A (da)	1978-09-26	Fremgangsmaade til fremstilling af oximderivater af 7-aminothiazolylacetamidocephalosporansyre
DK138879A (da)	1979-10-06	Fremgangsmaade til fremstilling af lysergolderivater
DK470978A (da)	1979-05-01	R fremgangsmaade til fremstilling af pyrazinobenzoxapinderivate
DK153489C (da)	1988-11-21	Analogifremgangsmaade til fremstilling af 7-aminothiazolylacetamidocephalosporansyrederivater
DK152130C (da)	1988-08-15	Fremgangsmaade til fremstilling af benzooebaathienopyridinderivater
DK494978A (da)	1979-05-08	Fremgangsmaade til fremstilling af 2-iminoimidazolidinderivater
DK150484C (da)	1987-10-05	Analogifremgangsmaade til fremstilling af 4-amino-3-thiophencarboxylsyrederivater
DK284977A (da)	1977-12-29	Fremgangsmade til fremstilling af cephemderivater
DK147197C (da)	1984-10-29	Analogifremgangsmaade til fremstilling af 2-hydrazonopropionsyrederivater
DK153377A (da)	1977-10-08	Fremgangsmade til fremstilling af cephemderivater
DK68978A (da)	1978-08-19	Fremgangsmaade til fremstilling af oximderivater af 3-thiadiazolythiomethyl-7-aminothiazolylacetamidocephalosporansyre
DK520178A (da)	1979-06-02	Fremgangsmaade til fremstilling af phenoxyalkanolamin-derivater